Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014

HERCULES, CA--(Marketwired - Oct 8, 2014) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, will report financial results for the third quarter 2014 on Tuesday, November 4, 2014, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

Interested parties may access the call by dialing 866-383-8009 (in the U.S.) or 617-597-5342 (international), passcode: 64852364. A live webcast of the conference call may be accessed in the Investor Relations section of www.bio-rad.com.

A replay of the call will be available at 888-286-8010 (in the U.S.) or 617-801-6888 (international), passcode: 34114260, for seven days following the call. The webcast of the call will be available on the Bio-Rad site for replay for up to a year and may be accessed in the Investor Relations section of www.bio-rad.com.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,800 people worldwide and had revenues exceeding $2.1 billion in 2013. For more information, visit our website at www.bio-rad.com.

Press Contacts:
Bio-Rad Laboratories, Inc.
Christine Tsingos, Executive Vice President and Chief Financial Officer
Ron Hutton, Vice President, Treasurer
510-724-7000